Estimation of the Prevalence of HIV, Hepatitis C and Hepatitis B Infection Among Detainees in the Nîmes Administrative Detention Center
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 350
- 试验地点
- 2
- 主要终点
- Prevalence of Hepatitis C infection in detainees at the Nîmes Administrative Detention Center
研究概览
简要总结
People in Administrative Detention Centers often come from areas of medium or high HIV, hepatitis C & B endemic, and are often unaware of their serological status. Currently, HIV, hepatitis C & B screening is not systematically performed at the CRA of Nîmes, and when performed, serological tests are used. The main disadvantage of this method is the length of time it takes to obtain the results, with subjects frequently discharged before receiving their results.
To improve the care of these vulnerable persons, the aim of this study is to estimate the prevalence of HIV, hepatitis C and hepatitis B in the detainees of the administrative detention center of Nîmes, by systematically screening with a rapid diagnosis test. In case of a positive rapid diagnosis test test, a serology test will confirm the rapid diagnosis test result.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •The patient must have given their free and informed oral consent
- •Patient detained in the Nîmes Administrative Detention Center
- •Exclusion Criterion
- •It is impossible to give the subject informed information
排除标准
- 未提供
结局指标
主要结局
Prevalence of Hepatitis C infection in detainees at the Nîmes Administrative Detention Center
时间窗: Inclusion
Rapid diagnosis test: Positive/negative
Prevalence of HIV infection in detainees at the Nîmes Administrative Detention Center
时间窗: Inclusion
Rapid diagnosis test: Positive/negative
Prevalence of Hepatitis B infection in detainees at the Nîmes Administrative Detention Center
时间窗: Inclusion
Rapid diagnosis test: Positive/negative
次要结局
- Knowledge of HIV, Hep C and Hep B status(Inclusion)
- Participant country of origin(Inclusion)
- Shared drug paraphernalia(Inclusion)
- Acceptability of the screening(End of study (1 year))
- Prevalence of co-infections between HIV, Hepatitis C and Hepatitis B(Inclusion)
- Intranasal drug use(Inclusion)
- Participant with piercings(Inclusion)
- Participant previous transfusion(Inclusion)
- Intravenous drug use(Inclusion)
- Non-protected sexual activity(Inclusion)
- Participant with tattoos(Inclusion)
- Feasibility of screening(End of study (1 year))